Literature DB >> 7812279

A pilot study of patient quality of life during radiation therapy treatment.

D J Johnson1, L Casey, B Noriega.   

Abstract

The purpose of this research was to develop a quality of life (QOL) tool that would help to reveal any physical, mental or emotional changes patients may experience while receiving radiation therapy. Research focusing on quality of life during radiation therapy is in its infancy. Although many tools to measure QOL have been developed, until very recently few had been geared specifically toward those receiving radiation therapy. In addition to a radiation-specific instrument, the goal was to develop a multidimensional measure that would be short in length and could be completed by the patient in 15 min or less. This new Quality of Life Radiation Therapy Instrument (QOL-RTI) is a visual analogue scale with 24 questions and is not site specific. Twenty-one patients with various diagnoses and treatment sites completed the questionnaire at baseline and then weekly during the course of radiation therapy. The internal consistency of the instrument (Cronbach's alpha) was 0.87. At baseline each patient also was asked to complete the Ferran's and Powers QLI Cancer Version 6 (QLIC); the correlation between the QLIC and the QOL-RTI was 0.47. These results are based on a small number of patients, but initial efforts in creating an instrument that is quick and easy for patients to complete have been encouraging. An additional 70-80 patients are now being entered into a study using the QOL-RTI to further evaluate reliability and validity.

Entities:  

Mesh:

Year:  1994        PMID: 7812279     DOI: 10.1007/bf00434900

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  27 in total

Review 1.  Validity of health-related quality of life subscales.

Authors:  G V Padilla
Journal:  Prog Cardiovasc Nurs       Date:  1992 Jan-Mar

Review 2.  Quality of life end points in cancer clinical trials: review and recommendations.

Authors:  C M Moinpour; P Feigl; B Metch; K A Hayden; F L Meyskens; J Crowley
Journal:  J Natl Cancer Inst       Date:  1989-04-05       Impact factor: 13.506

Review 3.  Quality-of-life assessment in cancer treatment protocols: research issues in protocol development.

Authors:  C C Gotay; E L Korn; M S McCabe; T D Moore; B D Cheson
Journal:  J Natl Cancer Inst       Date:  1992-04-15       Impact factor: 13.506

Review 4.  Measuring quality of life today: methodological aspects.

Authors:  D F Cella; D S Tulsky
Journal:  Oncology (Williston Park)       Date:  1990-05       Impact factor: 2.990

Review 5.  An introduction to test theory.

Authors:  D S Tulsky
Journal:  Oncology (Williston Park)       Date:  1990-05       Impact factor: 2.990

6.  Performance status assessment in cancer patients.

Authors:  C Conill; E Verger; M Salamero
Journal:  Cancer       Date:  1990-04-15       Impact factor: 6.860

7.  Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients.

Authors:  K Bjordal; S Kaasa
Journal:  Acta Oncol       Date:  1992       Impact factor: 4.089

8.  Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.

Authors:  H Schipper; J Clinch; A McMurray; M Levitt
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

9.  The Quality of Life Committee of the Clinical Trials Group of the National Cancer Institute of Canada: organization and functions.

Authors:  D Osoba
Journal:  Qual Life Res       Date:  1992-06       Impact factor: 4.147

Review 10.  Age and gender as factors in cancer therapy.

Authors:  P A Ganz
Journal:  Clin Geriatr Med       Date:  1993-02       Impact factor: 3.076

View more
  4 in total

1.  Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315.

Authors:  Babu Zachariah; Clement K Gwede; Jennifer James; Jaffer Ajani; Lisa J Chin; David Donath; Seth A Rosenthal; Brent L Kane; Marvin Rotman; Lawrence Berk; Lisa A Kachnic
Journal:  J Natl Cancer Inst       Date:  2010-03-25       Impact factor: 13.506

2.  Phase II trial of hyperfractionated intensity-modulated radiation therapy and concurrent weekly cisplatin for Stage III and IVa head-and-neck cancer.

Authors:  Patrick D Maguire; Michael Papagikos; Sue Hamann; Charles Neal; Martin Meyerson; Neil Hayes; Peter Ungaro; Kenneth Kotz; Marion Couch; Hoke Pollock; Joel Tepper
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-08       Impact factor: 7.038

Review 3.  A systematic review of head and neck cancer quality of life assessment instruments.

Authors:  Bukola Ojo; Eric M Genden; Marita S Teng; Kathrin Milbury; Krzysztof J Misiukiewicz; Hoda Badr
Journal:  Oral Oncol       Date:  2012-04-21       Impact factor: 5.337

4.  Translation and validation of the Chinese version of the Quality OF Life Radiation Therapy Instrument and the Head & Neck Module (QOL-RTI/H&N).

Authors:  Xin-lin Chen; Zhen-wen Qiu; Mo-fa Gu; Yong Su; Li-zhi Liu; Yan Liu; Chuan-wei Mo; Qian Xu; Juan Sun; Dong-hai Li
Journal:  Health Qual Life Outcomes       Date:  2014-04-14       Impact factor: 3.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.